Información del producto
Nombre:LY2955303
Marca:Biosynth
Descripción:LY2955303 is a synthetic retinoid that has been shown to be effective in the treatment of pancreatic cancer. LY2955303 acts by binding to all-trans retinoic acid receptors, which are expressed on the surface of cancer cells. This drug binds to the receptor and inhibits proliferation and induces apoptosis in pancreatic cancer cells. LY2955303 also inhibits esophageal adenocarcinoma cell proliferation, as well as inducing apoptosis via the same mechanism. The crystal structure of LY2955303 bound to an all-trans retinoic acid receptor has been determined using X-ray crystallography. The structure reveals that this drug interacts with a hydrophobic pocket on the surface of the receptor, preventing it from activating transcription factors inside the cell nucleus. LY2955303 also has pharmacokinetic properties similar to those of other retinoids, with a rapid absorption rate that is followed by a slow elimination phase.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:578.74 g/mol
Fórmula:C36H42N4O3
Pureza:Min. 95%
Consulta técnica sobre: LY2955303
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.